Headlines Covid-19 Specialties Trending Feeds Videos

Mashup Score: 8


We’re devoting this entire episode to the FDA’s polarizing decision to approve Aduhelm, a controversial Biogen treatment for

  • Was the FDA right to approve Aduhelm? What's a fair price for a debatable drug? And what does this have to do with ’80s HIV activism? All that and more on the latest episode of "The Readout LOUD." Listen now: https://t.co/1hZ7isQo4p - view on twitter